Connect Biopharma Holdings Ltd ·

CNTB 8-K 2026-09-30

Connect Biopharma Holdings Ltd (CNTB) 8-K dated 2026-09-30 — accession 0001835268-26-000038. This URL is the filing, not the CNTB hub.

Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.

Connect Biopharma Holdings Ltd filed a 8-K on 2026-09-30. Accession 0001835268-26-000038.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.

Not investment advice. The CNTB SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr